Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine the ability to use pharmacogenetic testing in a joint replacement practice to prescribe the most effective pain medicine for a specific patient.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Anderson Orthopaedic Research Institute
NCT06527664 · Bone Loss, Hip Prosthesis Infection, and more
NCT05845021 · Osteoporosis, Arthroplasty Complications, and more
NCT05216666 · Hip Osteoarthritis, Muscle Weakness, and more
NCT06523413 · Anxiety, Arthroplasty Complications
NCT06308965 · Tensor Fasciae Latae Syndrome, Arthroplasty Complications
Anderson Orthopaedic Research Institute
Alexandria, Virginia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions